Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Absence of PAF actions increases angiogenesis.

Literature DB >> 15023858

Absence of PAF actions increases angiogenesis.

Marina Ziche¹.

Abstract

Entities: Gene

Mesh：

Substances：

Year: 2004 PMID： 15023858 PMCID： PMC1574893 DOI： 10.1038/sj.bjp.0705728

Source DB: PubMed Journal: Br J Pharmacol ISSN： 0007-1188 Impact factor: 8.739

Keyword Cloud
References

× No keyword cloud information.

14 in total

Review 1. Chemokines and angiogenesis.

Authors: Z Szekanecz; A E Koch
Journal: Curr Opin Rheumatol Date: 2001-05 Impact factor: 5.006

2. Tumor angiogenesis is accompanied by a decreased inflammatory response of tumor-associated endothelium.

Authors: A W Griffioen; C A Damen; G H Blijham; G Groenewegen
Journal: Blood Date: 1996-07-15 Impact factor: 22.113

3. Platelet-activating factor enhances vascular endothelial growth factor-induced endothelial cell motility and neoangiogenesis in a murine matrigel model.

Authors: G Montrucchio; E Lupia; E Battaglia; L Del Sorbo; M Boccellino; L Biancone; G Emanuelli; G Camussi
Journal: Arterioscler Thromb Vasc Biol Date: 2000-01 Impact factor: 8.311

4. Interleukin-6 promotes cervical tumor growth by VEGF-dependent angiogenesis via a STAT3 pathway.

Authors: Lin-Hung Wei; Min-Liang Kuo; Chi-An Chen; Chia-Hung Chou; Kuo-Bau Lai; Chien-Nan Lee; Chang-Yao Hsieh
Journal: Oncogene Date: 2003-03-13 Impact factor: 9.867

5. Thrombopoietin stimulates endothelial cell motility and neoangiogenesis by a platelet-activating factor-dependent mechanism.

Authors: M F Brizzi; E Battaglia; G Montrucchio; P Dentelli; L Del Sorbo; G Garbarino; L Pegoraro; G Camussi
Journal: Circ Res Date: 1999-04-16 Impact factor: 17.367

Absence of PAF actions increases angiogenesis.

Review 1. Chemokines and angiogenesis.

2. Tumor angiogenesis is accompanied by a decreased inflammatory response of tumor-associated endothelium.

3. Platelet-activating factor enhances vascular endothelial growth factor-induced endothelial cell motility and neoangiogenesis in a murine matrigel model.

4. Interleukin-6 promotes cervical tumor growth by VEGF-dependent angiogenesis via a STAT3 pathway.

5. Thrombopoietin stimulates endothelial cell motility and neoangiogenesis by a platelet-activating factor-dependent mechanism.

6. Interleukin 1 is an autocrine regulator of human endothelial cell growth.

7. Abolished angiogenicity and tumorigenicity of Burkitt lymphoma by interleukin-10.

8. Induction of inflammatory angiogenesis by monocyte chemoattractant protein-1.

9. A continuous delivery system of IL-1 receptor antagonist reduces angiogenesis and inhibits tumor development.

10. Interleukin-10-mediated inhibition of angiogenesis and tumor growth in mice bearing VEGF-producing ovarian cancer.